Nina Bartelink wins CaRe Award 2020
Today our Caphri, (former) VHC colleague Nina Bartelink has won the “CaRe Award 2020” for her Cum Laude PhD thesis “Evaluating health promotion in complex adaptive school systems: The Healthy Primary School of the Future”. Bartelink concludes in her thesis that pupils, which are physical and mentally feeling well, perform better. In this way, their talents can develop optimal. Entering the program The Healthy Primary School of the Future requires “that the context of the school always will be included. That means that you have to watch broadly to teachers, pupils and parents and organization of the school,” Nina Bartelink says.
Education Foundation Movare started in November 2015 at four primary schools with the program The Healthy Primary School of the Future; at two schools structurally more time was set for moving. At two other schools, besides implementing more moving time on a structural base, a healthy lunch was included as well. This program includes another day rhythm, more moving, healthy food and social activities. Nina Bartelink researched the effect on nutrition, movement and the BMI of the pupils and the process flow.
Researcher
Nina is now busy using the gained knowledge in her work as a postdoc researcher at the department Health Promotion.
Award
CaRe is the national Researcherschool in which the VUMC and the AMC from Amsterdam, the Nivel from Utrecht, the RadboudUMC from Nijmegen and the MUMC+ from Maastricht participating. The CaRe Award is annually awarded by a independent jury and the managing board of CaRe to the doctoral candidate who wrote the best thesis in the year prior.
More information:
De Gezonde Basisschool van de Toekomst. Website:http://www.degezondebasisschoolvandetoekomst.nl/
E-mail: maartje.willeboordse@maastrichtuniversity.nl, n.bartelink@maastrichtuniversity.nl
Also read
-
Join 4 Energy Donates €50,000 for Muscle Stem Cell Therapy Research
Prof. Dr. Bert Smeets and his team has received a €50,000 donation from Join4Energy to advance their pioneering research using mesoangioblasts derived from the patient’s own body.
-
High impact paper in Nature Reviews Drug Discovery
High impact paper in Nature Reviews Drug Discovery
-
Denise Slenter Joins the BioSB Board as 'YoungCB' Portfolio Leader: request for PhD representative, and members
Denise Slenter Joins the BioSB Board as 'YoungCB' Portfolio Leader: request for PhD representative, and members